Alex Manno
Overview
Explore the profile of Alex Manno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Donovan L, Delaidelli A, Joseph S, Bielamowicz K, Fousek K, Holgado B, et al.
Nat Med
. 2021 May;
27(6):1117-1120.
PMID: 34045740
No abstract available.
2.
Donovan L, Delaidelli A, Joseph S, Bielamowicz K, Fousek K, Holgado B, et al.
Nat Med
. 2020 Apr;
26(5):720-731.
PMID: 32341580
Recurrent medulloblastoma and ependymoma are universally lethal, with no approved targeted therapies and few candidates presently under clinical evaluation. Nearly all recurrent medulloblastomas and posterior fossa group A (PFA) ependymomas...
3.
Garzia L, Kijima N, Morrissy A, De Antonellis P, Guerreiro-Stucklin A, Holgado B, et al.
Cell
. 2018 Jun;
173(6):1549.
PMID: 29856958
No abstract available.
4.
Garzia L, Kijima N, Morrissy A, De Antonellis P, Guerreiro-Stucklin A, Holgado B, et al.
Cell
. 2018 Feb;
172(5):1050-1062.e14.
PMID: 29474906
While the preponderance of morbidity and mortality in medulloblastoma patients are due to metastatic disease, most research focuses on the primary tumor due to a dearth of metastatic tissue samples...
5.
Morrissy A, Garzia L, Shih D, Zuyderduyn S, Huang X, Skowron P, et al.
Nature
. 2016 Jan;
529(7586):351-7.
PMID: 26760213
The development of targeted anti-cancer therapies through the study of cancer genomes is intended to increase survival rates and decrease treatment-related toxicity. We treated a transposon-driven, functional genomic mouse model...